Desparmet J, Mateo J, Ecoffey C, Mazoit X
Department of Anesthesiology, Hopital de Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, France.
Anesthesiology. 1990 Feb;72(2):249-51. doi: 10.1097/00000542-199002000-00007.
The effect of an intravenous (iv) injection of lidocaine with epinephrine was studied to determine if such a test dose would cause a reliably detectable increase in heart rate and systemic blood pressure in children anesthetized with halothane and nitrous oxide. The effect of the injection of atropine before the test dose on these parameters was also determined. Sixty-five children 1 month to 11 yr of age and weighing 3.9-35 kg were studied. The children were assigned to one of four groups, each of which was anesthetized with 1% halothane and 50% nitrous oxide. Group 1 (n = 20) received 10 micrograms/kg atropine followed 5 min later by an iv dose of 0.1 ml/kg 1% lidocaine with 1/200,000 epinephrine (0.5 micrograms/kg) to simulate an intravascularly administered epidural test dose. Group 2 (n = 21) was identical to group 1 but did not receive atropine prior to the simulated intravascular test dose. Groups 3 (n = 12) and 4 (n = 11) were identical to groups 1 and 2, but the simulated intravascular test dose did not contain epinephrine: group 3 received atropine prior to the test dose and group 4 did not. The simulated intravascular test dose increased heart rate in group 1 (with atropine) at each time period from 15 to 120 s, but only at 45 and 60 s in group 2 (without atropine). Following the iv test dose, 6 of 21 children in group 2 had an increase in heart rate of less than 10 beats/min, while only one child in group 1 had an increase in heart rate of less than 10 beats/min. Intravenous test doses that did not contain epinephrine (groups 3 and 4) had no effect on heart rate or blood pressure. Atropine, 10 micrograms/kg, improves the reliability of an epidural test dose in children anesthetized with halothane and nitrous oxide but does not ensure total reliability in detecting an intravascular injection.
研究了静脉注射利多卡因加肾上腺素的效果,以确定这样的试验剂量是否会使接受氟烷和氧化亚氮麻醉的儿童心率和全身血压出现可可靠检测到的升高。还确定了在试验剂量前注射阿托品对这些参数的影响。研究了65名年龄在1个月至11岁、体重3.9 - 35千克的儿童。这些儿童被分为四组,每组均用1%氟烷和50%氧化亚氮麻醉。第1组(n = 20)先接受10微克/千克阿托品,5分钟后静脉注射0.1毫升/千克 1%利多卡因加1/200,000肾上腺素(0.5微克/千克),以模拟血管内注射的硬膜外试验剂量。第2组(n = 21)与第1组相同,但在模拟血管内试验剂量前未接受阿托品。第3组(n = 12)和第4组(n = 11)与第1组和第2组相同,但模拟血管内试验剂量不含肾上腺素:第3组在试验剂量前接受阿托品,第4组未接受。模拟血管内试验剂量使第1组(使用阿托品)在15至120秒的每个时间段心率均升高,但第2组(未使用阿托品)仅在45秒和60秒时心率升高。静脉注射试验剂量后,第2组21名儿童中有6名心率升高不到10次/分钟,而第1组只有1名儿童心率升高不到10次/分钟。不含肾上腺素的静脉试验剂量(第3组和第4组)对心率和血压无影响。10微克/千克的阿托品可提高接受氟烷和氧化亚氮麻醉的儿童硬膜外试验剂量的可靠性,但不能确保在检测血管内注射时完全可靠。